Thyme Care
Series C in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Heartbeat Health
Series C in 2024
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.
Thyme Care
Venture Round in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Eleanor Health
Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Sempre Health
Venture Round in 2023
Sempre Health, Inc. operates a behavior-based healthcare pricing platform that collaborates with health plans and pharmaceutical manufacturers to offer dynamic co-payment adjustments based on individual patient adherence and behavior. Founded in 2015 and based in San Francisco, the company analyzes prescription records to forecast the most appropriate price for medications based on a patient's timely adherence. Patients receive personalized SMS messages that inform them of potential discounts and encourage prompt prescription refills, such as alerts indicating that filling a prescription today may cost $10, while delaying could raise the price to $30. This innovative approach not only aims to improve patients' access to affordable care but also generates valuable real-world data on patient price sensitivities and cost behaviors.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
Strive Health
Series C in 2023
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.
Medix Infusion
Series B in 2023
Medix Infusion, Inc. is a healthcare provider based in Arlington, Texas, specializing in ambulatory and home infusion therapy services for patients with chronic and acute illnesses. Established in 2020, the company offers a range of pharmacy services, including the placement of PICC lines, and the administration of anti-infectives, anti-virals, IV antibiotics, anti-fungals, biologics, specialty injectables, total parenteral nutrition (TPN), and hydration therapy. Medix Infusion is committed to enhancing patient care by delivering personalized infusion therapies both at home and in clinical settings. The company focuses on serving patients in rural and underserved areas, ensuring access to essential physician-prescribed medical treatments. Its technology-enabled platform aims to improve the overall healthcare experience for those requiring specialized infusion therapies.
DispatchHealth
Venture Round in 2022
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.
Upfront Healthcare Services
Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that develops a data analytics platform aimed at improving the efficiency of physician practices in managing patient care. Founded in 2015, the company focuses on enhancing the ambulatory experience by automating and personalizing care navigation, which helps to engage patients effectively and optimize resource allocation. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients towards appropriate care options while addressing their specific needs. By offering insights derived from demographics, billing, scheduling, claims, and care gap data, Upfront Healthcare Services aims to increase appointment completion rates and improve health outcomes across healthcare systems.
Abacus Insights
Series C in 2022
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
Waltz Health
Series A in 2022
Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.
Embold Health
Series B in 2022
Embold Health, Inc. is a healthcare analytics company based in Nashville, Tennessee, that specializes in analyzing de-identified medical data to evaluate the quality and cost of care provided by doctors and hospitals. Founded in 2017, the company offers a platform that enables employers, health plans, and consumers to identify top-performing healthcare providers who deliver appropriate care. By utilizing insights from its analytics, Embold Health aims to improve healthcare outcomes and facilitate informed decision-making for patients and their families. Additionally, their online search platform allows users to access medical research and clinical guidelines, further supporting the selection of quality care options.
Wildflower Health
Venture Round in 2022
Wildflower Health, Inc. provides smartphone-based health programs aimed at connecting healthcare payers with families in the United States. Founded in 2012 and headquartered in San Francisco, the company offers a maternity program called Due Date Plus, which engages women early in pregnancy and connects them with healthcare providers or care managers. Additionally, Wildflower Health provides GROW, a family health program that focuses on mothers and encompasses pediatric and family health needs. The platform delivers personalized health milestones based on age and gender, integrates client resources, and offers features such as on-device messaging, appointment reminders, health risk assessments, and clinical referrals. By leveraging user-centered design and technology, Wildflower Health seeks to promote smarter healthcare decisions and improve health outcomes for families over time.
Scipher Medicine
Series D in 2022
Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.
mPulse Mobile
Venture Round in 2022
mPulse Mobile, Inc. develops healthcare communication technology solutions focused on consumer health and wellness. The company offers a cloud-based intelligent mobile messaging platform designed to address various challenges in healthcare, including missed appointments, medication adherence, and disease management. Its solutions encompass medication adherence, preventive care, chronic condition management, and optimizing call center operations, serving a diverse clientele that includes Medicare, Medicaid, commercial plans, health systems, and pharmacies. By integrating conversational AI and digital engagement strategies, mPulse Mobile helps healthcare organizations encourage customers to adopt healthier behaviors. Founded in 2014, the company is headquartered in Encino, California.
Genome Medical
Series C in 2021
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Main Street Health
Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.
Eleanor Health
Series B in 2021
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Heartbeat Health
Series B in 2021
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.
Ideon develops a healthcare data platform for the employee benefits sector. Its suite of application programming interfaces provides the infrastructure, or middleware, to help insurance and digital health companies access flows of data, creating modern digital experiences throughout the employee benefits ecosystem.
Scipher Medicine
Series C in 2021
Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.
Strive Health
Series B in 2021
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
DispatchHealth
Series D in 2021
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
Upfront Healthcare Services
Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that develops a data analytics platform aimed at improving the efficiency of physician practices in managing patient care. Founded in 2015, the company focuses on enhancing the ambulatory experience by automating and personalizing care navigation, which helps to engage patients effectively and optimize resource allocation. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients towards appropriate care options while addressing their specific needs. By offering insights derived from demographics, billing, scheduling, claims, and care gap data, Upfront Healthcare Services aims to increase appointment completion rates and improve health outcomes across healthcare systems.
mPulse Mobile
Series C in 2020
mPulse Mobile, Inc. develops healthcare communication technology solutions focused on consumer health and wellness. The company offers a cloud-based intelligent mobile messaging platform designed to address various challenges in healthcare, including missed appointments, medication adherence, and disease management. Its solutions encompass medication adherence, preventive care, chronic condition management, and optimizing call center operations, serving a diverse clientele that includes Medicare, Medicaid, commercial plans, health systems, and pharmacies. By integrating conversational AI and digital engagement strategies, mPulse Mobile helps healthcare organizations encourage customers to adopt healthier behaviors. Founded in 2014, the company is headquartered in Encino, California.
Cityblock
Series B in 2020
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
DispatchHealth
Series C in 2020
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.
Abacus Insights
Series B in 2020
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
Amwell is a telehealth platform based in the United States that connects healthcare providers, insurers, patients, and innovators to enhance access to affordable and high-quality medical care. Founded in 2006 and headquartered in Boston, the company offers a comprehensive platform to address various telehealth needs, including urgent and acute care, post-acute care, chronic care management, and healthy living. With over a decade of experience, Amwell serves more than 240 health systems, comprising 2,000 hospitals and 55 health plan partners, and reaches over 150 million individuals, including 36,000 employers. The platform supports both on-demand and scheduled consultations, providing solutions for primary care, specialty consults, and chronic care programs like musculoskeletal and dermatology care.
Aledade, Inc. is a health technology company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and based in Bethesda, Maryland, Aledade partners with independent primary care providers to offer a comprehensive suite of services, including data analytics, guided workflows, regulatory expertise, and payer relationships. The company also provides 360° practice support, workflow optimization, and assistance with ACO governance and contracting. By leveraging its technology platform, Aledade enables physicians to access integrated data and insights that help improve patient care, reduce costs, and maintain the autonomy of independent practices. Its tailored solutions cater to a diverse range of healthcare providers, including small practices, large practices, community health centers, and multispecialty groups.
TytoCare
Venture Round in 2020
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.
Aitia specializes in applying Causal AI and Digital Twins to advance drug discovery and development. The company utilizes multi-omic patient data and high-performance computing to uncover the underlying biological mechanisms of diseases, creating Digital Twins for conditions such as oncology, neurodegenerative disorders, and immunology. Their Gemini Digital Twins are actively employed to explore new therapies and expedite research and development in areas like multiple myeloma, prostate cancer, Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, with additional projects in the pipeline. Aitia collaborates with seven of the top ten pharmaceutical companies, academic research institutions, medical societies, multi-omic data firms, and patient advocacy organizations, positioning itself as a leader in the innovative intersection of technology and healthcare.
Genome Medical
Series B in 2019
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.
Abacus Insights
Series A in 2019
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
DispatchHealth
Series B in 2019
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.
Strive Health
Seed Round in 2019
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Aledade
Corporate Round in 2019
Aledade, Inc. is a health technology company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and based in Bethesda, Maryland, Aledade partners with independent primary care providers to offer a comprehensive suite of services, including data analytics, guided workflows, regulatory expertise, and payer relationships. The company also provides 360° practice support, workflow optimization, and assistance with ACO governance and contracting. By leveraging its technology platform, Aledade enables physicians to access integrated data and insights that help improve patient care, reduce costs, and maintain the autonomy of independent practices. Its tailored solutions cater to a diverse range of healthcare providers, including small practices, large practices, community health centers, and multispecialty groups.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
AccessOne
Venture Round in 2018
AccessOne is a healthcare fintech company established in 2002 and based in Fort Mill, South Carolina. The company specializes in providing patient-centric payment tools designed to assist consumers in managing their healthcare costs while enhancing hospital reimbursement. AccessOne offers a range of low and no-interest payment options for various patient balance types, including high-deductible plans and financial assistance, ensuring that no patient is denied credit or negatively impacted in their credit reporting. The company’s financial engagement platform focuses on automation, digitization, and effective communication, seamlessly integrating with major health information systems to streamline processes and improve performance metrics for healthcare providers. By eliminating manual entry and facilitating better revenue capture, AccessOne supports hospitals and health systems in achieving optimal financial outcomes.
mPulse Mobile
Series B in 2018
mPulse Mobile, Inc. develops healthcare communication technology solutions focused on consumer health and wellness. The company offers a cloud-based intelligent mobile messaging platform designed to address various challenges in healthcare, including missed appointments, medication adherence, and disease management. Its solutions encompass medication adherence, preventive care, chronic condition management, and optimizing call center operations, serving a diverse clientele that includes Medicare, Medicaid, commercial plans, health systems, and pharmacies. By integrating conversational AI and digital engagement strategies, mPulse Mobile helps healthcare organizations encourage customers to adopt healthier behaviors. Founded in 2014, the company is headquartered in Encino, California.
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that focuses on providing integrated solutions for individuals with chronic conditions, particularly diabetes. Founded in 2008, Livongo combines advanced technology with personalized coaching to empower users in managing their health. Its platform includes cellular-connected devices and data-driven insights, facilitating real-time support for diabetes management while also addressing hypertension, prediabetes, weight management, and behavioral health. Livongo serves a diverse clientele, including employers, health plans, government entities, and labor unions, aiming to improve both clinical outcomes and user experience in chronic disease management. In 2020, Livongo became a subsidiary of Teladoc Health, further expanding its reach in the healthcare market.
Springbuk
Series B in 2018
Springbuk provides a health analytics software solution to prevent disease with data. Its health intelligence platform unifies medical claims, pharmacy, biometric, and activity data. The predictive modeling engine helps employers target their engagement with pinpoint accuracy, forecast overall healthcare spending, identify at-risk employees, and measure their wellness programs. The company was founded in 2015 and is headquartered in Indianapolis, Indiana.
Circulation
Series A in 2017
Circulation, Inc. is a Boston-based company founded in 2016 that offers a digital platform designed to enhance healthcare logistics and transportation. By leveraging the Uber driver network, Circulation facilitates non-emergency transportation for patients and clinical trial participants, ensuring they can attend medical appointments. As a preferred healthcare partner of Uber, the platform provides customizable solutions that improve the efficiency and outcomes of healthcare delivery across the United States. The service is utilized by a diverse range of users, including patients, caregivers, and healthcare providers, and is designed to comply with the Health Insurance Portability and Accountability Act (HIPAA), ensuring the privacy and security of patient information. Circulation operates as a subsidiary of LogistiCare Solutions, LLC.
Upfront Healthcare Services
Series A in 2017
Upfront Healthcare Services, Inc. is a Chicago-based company that develops a data analytics platform aimed at improving the efficiency of physician practices in managing patient care. Founded in 2015, the company focuses on enhancing the ambulatory experience by automating and personalizing care navigation, which helps to engage patients effectively and optimize resource allocation. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients towards appropriate care options while addressing their specific needs. By offering insights derived from demographics, billing, scheduling, claims, and care gap data, Upfront Healthcare Services aims to increase appointment completion rates and improve health outcomes across healthcare systems.
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.